Andrew Ray is a rising third year medical student at the University of Louisville School of Medicine. He completed his Bachelor’s degree in Chemical Science at Xavier University and went on to complete a Master’s in Pharmacology at the University of Cincinnati College of Medicine. Ray is also enrolled and expected to complete a Master’s of Business Administration at the University of Louisville School of Business in 2022.
During his studies at Xavier University, Ray assisted with development of point-of-care sensor technologies for laboratory diagnosis of Manganese toxicity following discovery of environmental contamination eastern Ohio in early 2011. During his graduate studies, Ray contributed to drug target and candidate development for both Cincinnati Children’s Hospital and the University of Cincinnati College of Medicine. Following graduate studies, Ray contributed to development of a first of its kind treatment for cocaine addiction in the lab of two of his graduate mentors Dr. Terry Kirley and Dr. Andrew Norman.
A more in depth look at Andrew Ray can be found here: https://kyma.org/community-health-advocacy/kma-leadership-programs/medical-student-outreach-and-leadership-program/
Read more about the heavy metal disaster in Ohio here: https://www.epa.gov/healthresearch/studying-manganese-exposure-eastern-ohio
Read more about the lab on chip project here: https://www.soapboxmedia.com/innovationnews/89manganese.aspx
Read more about the first treatment to reach clinical trials for cocaine addiction here: https://www.cincinnati.com/story/news/2017/03/06/cocaine-blocker-could-help-fight-heroin-opiates-too/98798984/